Nexstim’s business partner PO Medica AB has sold two Navigated Brain Therapy (NBT) systems to two different hospitals Sweden.
Both hospitals will be the first in Sweden to have the NBT systems and it will be their first time using navigated Transcranial Magnetic Stimulation (TMS) for the treatment of MDD. The systems will be used for the treatment of depression in patients who failed to respond to antidepressant medications.
An important milestone
“We are happy to see that Nexstim’s SmartFocus TMS technology will now be used also for the therapy applications in Sweden, like we have seen before in every University Hospital in Finland. Following these first sales we believe further clinics and patients in Sweden will see the benefits of the NBT system for the treatment of MDD,” says Per Olander, owner and CEO of PO Medica AB, Nexstim’s distributor in Scandinavia.
“We are pleased that Nexstim, who already has several NBS systems installed in Sweden, is now entering the Swedish depression therapy market with multiple NBT system sales. Placing the NBT systems in Sweden marks an important milestone for us as we look to strengthen our focus on depression treatment,” says Martin Jamieson, Chairman and CEO, Nexstim plc.